|
Volumn 52, Issue 5, 2001, Pages 619-625
|
Evidence-based pharmacologic treatment for people with severe mental illness: A focus on guidelines and algorithms
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
ANTICONVULSIVE AGENT;
CLOZAPINE;
DESIPRAMINE;
LITHIUM;
NEUROLEPTIC AGENT;
NORTRIPTYLINE;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROIC ACID;
AFFECTIVE NEUROSIS;
ALGORITHM;
ANXIETY NEUROSIS;
CLINICAL PRACTICE;
COOPERATION;
DISEASE SEVERITY;
DRUG CHOICE;
ELECTROCONVULSIVE THERAPY;
EVIDENCE BASED MEDICINE;
HEALTH CARE QUALITY;
HUMAN;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
MENTAL DISEASE;
OBSESSION;
PANIC;
POSTTRAUMATIC STRESS DISORDER;
PRACTICE GUIDELINE;
PRESCRIPTION;
PSYCHOPHARMACOLOGY;
PSYCHOSIS;
REVIEW;
DEPRESSIVE DISORDER;
EVIDENCE-BASED MEDICINE;
HUMANS;
MENTAL DISORDERS;
PANIC DISORDER;
PRACTICE GUIDELINES;
PSYCHIATRY;
PSYCHOTIC DISORDERS;
PSYCHOTROPIC DRUGS;
SCHIZOPHRENIA;
|
EID: 0035019913
PISSN: 10752730
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ps.52.5.619 Document Type: Review |
Times cited : (65)
|
References (42)
|